Drug Trial Radar · NCT02174731
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.
Last checked: Nov 19, 2026Latest source record: Dec 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,133
Actual
Start
Jul 1, 2014
Primary completion
Sep 26, 2018
Study completion Sep 26, 2018
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Kyntra Bio
- First posted
- Jun 25, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of roxadustat compared to epoetin alfa for the treatment of anemia in chronic kidney disease patients on dialysis.
Conditions
- Anemia
Interventions
RoxadustatDrug
Roxadustat will be administered orally three times a week (TIW) to achieve an Hb level of 11 g/dL and maintain a Hb level of 11±1 g/dL.
Epoetin alfaDrug
Epoetin alfa will be administered TIW consistent with approved prescribing information for epoetin alfa to achieve an Hb level of 11 g/dL and maintain a Hb level of 11±1 g/dL.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Hb Averaged Over Week 28 to Week 52Time frame: Baseline (Day 1, Week 0), Week 28 to 52
Locations
188 sites in 18 countries. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama
Research Site
El Centro, California
Research Site
Fairfield, California
Research Site
Glendale, California
Research Site
Long Beach, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Lynwood, California
Research Site
Northridge, California
Research Site
Ontario, California
Research Site
Orange, California
Research Site
Riverside, California
Research Site
Sacramento, California
Research Site
Sun Valley, California
Research Site
Whittier, California
Research Site
Whittier, California
Research Site
Denver, Colorado
Research Site
New Haven, Connecticut
Research Site
Miami Gardens, Florida
Research Site
River Forest, Illinois
Research Site
Wichita, Kansas
Research Site
Baton Rouge, Louisiana
Research Site
Lanham, Maryland
Research Site
Plymouth, Massachusetts
Research Site
Roseville, Michigan
Research Site
Gulfport, Mississippi
Research Site
Kansas City, Missouri
Research Site
Reno, Nevada
Research Site
Paterson, New Jersey
Research Site
Great Neck, New York
Research Site
Orchard Park, New York
Research Site
The Bronx, New York
Research Site
Asheville, North Carolina
Research Site
Charlotte, North Carolina
Research Site
Wilmington, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Shawnee, Oklahoma
Research Site
Bethlehem, Pennsylvania
Research Site
Philadelphia, Pennsylvania
Showing 40 of 188 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.